Inventor · disambiguated record
Jason Dehart
Also filed as: DEHART JASON · DEHART JASON L · DEHART JASON LEE
7 granted patents·10 pending applications·15 citations·filing 2006–2024
77Inventor score
Files withJANSSEN PHARMACEUTICALS INC8JANSSEN BIOTECH INC4SALK INST FOR BIOLOGICAL STUDI3JANSSEN SCIENCES IRELAND UNLIMITED CO1UNIV UTAH RES FOUND1
Top patents by PatentIndex Score
17 records- 0194US11083786B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·13 cites·24 claims
- 0287US11826416B2Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2021·Granted Nov 28, 2023·1 cites·24 claims
- 0381US2025134941A1Hsv-1 oncolytic virus therapies that specifically kill alt dependent cancersSALK INST FOR BIOLOGICAL STUDI·Filed 2024·Application pending·0 cites
- 0480US10821141B2HSV-1 oncolytic virus therapies that specifically kill ALT dependent cancersSALK INST FOR BIOLOGICAL STUDI·Filed 2018·Granted Nov 3, 2020·1 cites·15 claims
- 0576US2024042005A1Induce and enhance immune responses using recombinant replicon systemsJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0675US2024209379A1Compositions and methods for enhancing gene expressionJANSSEN PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0768US2024294884A1Vaccines based on mutant calr and jak2 and their usesJANSSEN BIOTECH INC·Filed 2024·Application pending·0 cites
- 0864US2021220417A1Hsv-1 oncolytic virus therapies that specifically kill alt dependent cancersSALK INST FOR BIOLOGICAL STUDI·Filed 2020·Application pending·0 cites
- 0961US12295997B2Prostate neoantigens and their usesJANSSEN BIOTECH INC·Filed 2021·Granted May 13, 2025·0 cites·31 claims
- 1060US11845939B2Compositions and methods for enhancing gene expressionJANSSEN PHARMACEUTICALS INC·Filed 2017·Granted Dec 19, 2023·0 cites·50 claims
- 1159US12018289B2Vaccines based on mutant CALR and JAK2 and their usesJANSSEN BIOTECH INC·Filed 2020·Granted Jun 25, 2024·0 cites·26 claims
- 1252US2022016237A1Rna replicon vaccines against hbvJANSSEN SCIENCES IRELAND UNLIMITED CO·Filed 2021·Application pending·0 cites
- 1352US2023024133A1Prostate Neoantigens And Their UsesJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 1451US12331076B2Alphavirus-based replicons for administration of biotherapeuticsJANSSEN PHARMACEUTICALS INC·Filed 2019·Granted Jun 17, 2025·0 cites·20 claims
- 1551US2021346492A1SARS-CoV-2 VaccinesJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1651US2021347828A1RNA Replicon Encoding a Stabilized Corona Virus Spike ProteinJANSSEN PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1748US2006216823A1Method for obtaining an enriched population of siRNA-expressing cellsUNIV UTAH RES FOUND·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →